Indeed, its function relies on increasing insulin-mediated glucose uptake by activating the protein kinase B (PKB or Akt) pathway, and decreased serum concentrations have been detected in individuals with obesity and T2DM [82,85]. This evidence concerns the gene AKT1 and Obesity.